Frequently asked questions about Molecular Cancer

Karsta Lüttich¹ , Christian Schmidt²^,3 and Guido M Sclabas³

¹Department of Dermatology, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York, 10021, USA

²Editor-in-Chief, Molecular Cancer, BioMed Central Ltd, Middlesex House, 34–42 Cleveland Street, London W1T 4LB, UK

³Department of Surgical Oncology and Molecular Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA

author email corresponding author email

Molecular Cancer 2003, 2:16doi:10.1186/1476-4598-2-16


Published:	31 January 2003

Abstract

Molecular Cancer is as a forum for cutting edge cancer-related papers. This editorial will answer frequently asked question about this open-access and on-line journal as well as its publisher BioMed Central.